BC treatment is decided according to the subtype, and the most common treatments are surgery, radiation, chemotherapy, hormonal therapy (for tumors that express estrogen and progesterone receptors), targeted therapy (especially directed to HER2 in HER2-enriched BC) and immunotherapy [25,26,27]. This evidence concerns the gene ERBB2 and breast cancer.